Published in Pancreas on May 01, 2012
Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine. Med Sci Monit (2013) 1.03
Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Front Immunol (2014) 0.97
Strategies for discovering novel pancreatic cancer biomarkers. J Proteomics (2012) 0.96
The human HSP70 family of chaperones: where do we stand? Cell Stress Chaperones (2016) 0.95
Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. Radiat Oncol (2014) 0.89
The chaperone balance hypothesis: the importance of the extracellular to intracellular HSP70 ratio to inflammation-driven type 2 diabetes, the effect of exercise, and the implications for clinical management. Mediators Inflamm (2015) 0.86
Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma. PLoS One (2015) 0.84
Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites. Oncotarget (2016) 0.79
Blockade of PI3K/AKT pathway enhances sensitivity of Raji cells to chemotherapy through down-regulation of HSP70. Cancer Cell Int (2013) 0.78
Extracellular cell stress (heat shock) proteins-immune responses and disease: an overview. Philos Trans R Soc Lond B Biol Sci (2018) 0.76
Evidence of multimeric forms of HSP70 with phosphorylation on serine and tyrosine residues--implications for roles of HSP70 in detection of GI cancers. Asian Pac J Cancer Prev (2013) 0.76
Primary and liver metastasis-derived cell lines from KrasG12D; Trp53R172H; Pdx-1 Cre animals undergo apoptosis in response to triptolide. Pancreas (2015) 0.76
Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. Cent Eur J Immunol (2017) 0.75
Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer. Oncoimmunology (2017) 0.75
Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90. Nat Commun (2017) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol (2006) 4.22
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol (2006) 3.24
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol (2009) 3.22
Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer (2005) 2.20
Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Cancer Res (1987) 2.14
PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. Clin Cancer Res (2007) 2.06
Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res (2007) 1.87
The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur J Surg Oncol (2005) 1.77
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res (2004) 1.74
Tumor M2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis. Pancreas (2007) 1.45
CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas (2007) 1.39
Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg (2002) 1.31
CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice. J Surg Oncol (2007) 1.30
Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer. Cancer Res (2007) 1.21
Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes. Br J Cancer (2005) 1.18
Stress kinases and heat shock proteins in the pancreas: possible roles in normal function and disease. J Gastroenterol (2000) 1.17
Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head. Hepatobiliary Pancreat Dis Int (2007) 1.14
Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy. Eur J Surg Oncol (2008) 1.11
Progress on molecular markers of pancreatic cancer. Curr Opin Gastroenterol (2007) 1.11
Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma. J Am Coll Surg (2007) 1.09
Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. Hepatogastroenterology (2003) 1.05
Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res (1994) 0.98
Heat shock proteins in pancreatic diseases. J Gastroenterol Hepatol (2008) 0.97
Perioperative management of pancreatic cancer. Ann Oncol (2008) 0.96
Serological detection of heat shock protein hsp27 in normal and breast cancer patients. Cancer Epidemiol Biomarkers Prev (1998) 0.95
Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma. Pancreas (2009) 0.91
Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma. J Gastroenterol (2009) 0.90
Neoadjuvant therapy for pancreatic cancer. J Gastrointest Surg (2008) 0.90
Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy. Anticancer Res (1996) 0.85
Microarray technologies for gene transcript analysis in pancreatic cancer. Technol Cancer Res Treat (2008) 0.84
Neoadjuvant treatment for pancreatic cancer--a review. Crit Rev Oncol Hematol (2007) 0.84
Clinical relevance of serological markers in the detection and follow-up of pancreatic adenocarcinoma. Surg Oncol (1996) 0.81
Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology (2009) 4.08
Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr (2003) 3.34
Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Ann Surg (2012) 2.93
Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer technique? Ann Surg (2011) 2.87
Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg (2008) 2.80
Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg (2014) 2.15
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol (2008) 2.15
Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2012) 1.97
A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg (2010) 1.83
Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics (2004) 1.82
Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis. Mol Cancer Ther (2010) 1.67
Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer. Clin Cancer Res (2008) 1.66
Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth. Clin Cancer Res (2011) 1.55
Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"? J Gastrointest Surg (2013) 1.52
Metastatic methicillin-sensitive Staphylococcus aureus infection. South Med J (2011) 1.38
Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia. Clin Gastroenterol Hepatol (2006) 1.32
Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One (2013) 1.24
Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system. J Gastrointest Surg (2010) 1.14
Src-mediated regulation of E-cadherin and EMT in pancreatic cancer. Front Biosci (Landmark Ed) (2012) 1.13
Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol (2010) 1.00
Endoscopic ultrasound and computed tomography predictors of pancreatic cancer resectability. J Gastrointest Surg (2007) 0.99
Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology (2014) 0.98
Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection. HPB (Oxford) (2012) 0.98
Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells. Onco Targets Ther (2013) 0.97
Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. Cancer Res (2014) 0.95
Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology (2014) 0.90
Gastric schwannoma. Am Surg (2008) 0.87
Epidemiology of Clostridium difficile-associated disease (CDAD): a shift from hospital-acquired infection to long-term care facility-based infection. Dig Dis Sci (2013) 0.86
Organic anion transporting polypeptide 1B3 (OATP1B3) is overexpressed in colorectal tumors and is a predictor of clinical outcome. Clin Exp Gastroenterol (2008) 0.85
Periampullary leiomyosarcoma presenting with cutaneous metastases: a rare entity. South Med J (2010) 0.85
Exfoliated colonic epithelial cells: surrogate targets for evaluation of bioactive food components in cancer prevention. J Nutr (2005) 0.85
Synchronous bone marrow metastasis from primary splenic angiosarcoma. Am Surg (2010) 0.84
Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms. Liver Transpl (2014) 0.83
Intensity of follow-up after pancreatic cancer resection. Ann Surg Oncol (2013) 0.83
Is Stauffer's syndrome an early indicator of RCC recurrence? ANZ J Surg (2010) 0.83
Commentary: The role of global surgery electives during residency training: relevance, realities, and regulations. Surgery (2012) 0.83
Clinical evaluation, imaging studies, indications for cytologic study, and preprocedural requirements for duct brushing studies and pancreatic FNA: the Papanicolaou Society of Cytopathology recommendations for pancreatic and biliary cytology. Diagn Cytopathol (2014) 0.82
Terminal ileal carcinoid tumor without hepatic or extrahepatic metastasis causing carcinoid syndrome. Am Surg (2013) 0.82
A clinical comparative analysis of crush/clamp, stapler, and dissecting sealer hepatic transection methods. HPB (Oxford) (2008) 0.82
Sirolimus based immunosuppression is associated with need for early repeat therapeutic ERCP in liver transplant patients with anastomotic biliary stricture. Ann Hepatol (2013) 0.82
Induced thrombospondin expression in the mouse pancreas during pancreatic injury. Int J Biochem Cell Biol (2005) 0.82
Mucosal Schwann cell hamartoma: just benign or more? Int J Colorectal Dis (2014) 0.82
Trends in the use of evidence-based therapy for resectable gastric cancer. J Surg Oncol (2014) 0.81
Diagnosis and Treatment of Cerebral Salt Wasting Syndrome With Cryptococcal Meningitis in HIV Patient. Am J Ther (2016) 0.81
Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy. Expert Rev Proteomics (2010) 0.81
Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients. Ann Surg (2014) 0.81
Postbrushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: the Papanicolaou Society of Cytopathology guidelines. Diagn Cytopathol (2014) 0.80
Administration of oxaliplatin to a pregnant woman with rectal cancer. Cancer Chemother Pharmacol (2008) 0.80
Granulocyte colony stimulating factor secreting hepatocellular carcinoma. Am Surg (2012) 0.80
Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol (2012) 0.80
Role of endoscopic ultrasound/SpyScope in diagnosis and treatment of choledocholithiasis in pregnancy. World J Gastroenterol (2010) 0.80
Incidence of additional primary malignancies in patients with pancreatic and gastrointestinal neuroendocrine tumors. Ann Surg Oncol (2014) 0.79
An Unrecognized Rash Progressing to Lyme Carditis: Important Features and Recommendations Regarding Lyme Disease. Am J Ther (2016) 0.79
Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinoma. Int J Clin Exp Pathol (2013) 0.79
Genomics and proteomics in predicting cancer outcomes. Surg Oncol Clin N Am (2008) 0.79
Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response. Pancreas (2016) 0.79
53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma. BMC Cancer (2013) 0.79
Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer. Arch Surg (2009) 0.79
Apoptotic mechanisms in fulminant hepatic failure: potential therapeutic target. Appl Immunohistochem Mol Morphol (2009) 0.77
Barrett's esophagus and β-carotene therapy: symptomatic improvement in GERD and enhanced HSP70 expression in esophageal mucosa. Asian Pac J Cancer Prev (2012) 0.77
Evidence for enhanced telomerase activity in Barrett's esophagus with dysplasia and adenocarcinoma. Asian Pac J Cancer Prev (2013) 0.77
HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience. Ann Transplant (2013) 0.76
Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome. J Pediatr Gastroenterol Nutr (2014) 0.76
Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma. PLoS One (2013) 0.76
Evidence of multimeric forms of HSP70 with phosphorylation on serine and tyrosine residues--implications for roles of HSP70 in detection of GI cancers. Asian Pac J Cancer Prev (2013) 0.76
Authors' reply: High-resolution manometry in swallow syncope-is there a role? Saudi J Gastroenterol (2014) 0.75
Young alcoholic patient with acute vision loss: pancreatitis-related or a marker of underlying autoimmune disease. BMJ Case Rep (2014) 0.75
Helicobacter pylori-negative Russell body gastritis: does the diagnosis call for screening for plasmacytic malignancies, especially multiple myeloma? BMJ Case Rep (2014) 0.75
Direct cardiac invasion of hepatocellular carcinoma with ball-valve phenomenon. Am Surg (2011) 0.75
Cardiogenic dysphagia: an unusual case. Saudi J Gastroenterol (2012) 0.75
Difficult endoscopic hemostasis of post-sphincterotomy bleeding--look beyond aspirin and NSAIDs. Clin Res Hepatol Gastroenterol (2013) 0.75
Is short-term percutaneous endoscopic gastrostomy tube placement beneficial in acutely ill cognitively intact elderly patients? A proposed decision-making algorithm. Geriatr Gerontol Int (2014) 0.75
Isolated renal mucormycosis in a healthy immunocompetent patient: atypical presentation and course. Korean J Urol (2013) 0.75
Appendiceal adenocarcinoma presenting as venous thromboembolism: an unusual presentation of a rare carcinoma. Am Surg (2010) 0.75
Role of early surgery in spontaneous enterocutaneous tubercular fistulae. Saudi J Gastroenterol (2010) 0.75
A rare cause of gastrointestinal bleeding: endoscopic venous malformations, but not vasculitis. Clin Res Hepatol Gastroenterol (2013) 0.75
Surgical care and career opportunities in a changing practice paradigm. J Am Coll Surg (2013) 0.75
Testicular seminoma metastasis to pancreas: a rare cause of obstructive jaundice. N Z Med J (2010) 0.75
FIBROVASCULAR POLYP: AN UNUSUAL MASS IN THE ESOPHAGUS CAUSING DYSPHAGIA. J Ark Med Soc (2016) 0.75
Inflammatory pseudotumour of the liver: a diagnostic dilemma. Trop Gastroenterol (2008) 0.75
Multifocal epitheloid hemangioendothelioma of liver after long-term oral contraceptive use--a case report and discussion of management difficulties encountered. J Gastrointest Cancer (2009) 0.75
A diagnostic dilemma of new onset ascites: think beyond the liver. J Ark Med Soc (2015) 0.75
High Rate of Pancreatic Structural Changes Among Tobacco-Using Individuals at High Risk for Pancreatic Ductal Adenocarcinoma Undergoing Endoscopic Ultrasound. Pancreas (2022) 0.75
Atypical gastric ulcer with characteristic eschar appearance. N Z Med J (2010) 0.75
Changes in S-PSA after transurethral resection of prostate and its correlation to postoperative outcome. Int Urol Nephrol (2013) 0.75